bpc-157 fda warning 2025 scientists flag concerns with peptides as RFK Jr. tries to ease access : NPR FDA Targets GLP-1 and Peptide

Week 3: I deliberately increased training volume to test if this was just recovery from backing off

[1] In moderate deficiencies, feeling tired, feeling faint, mouth ulcers, rapid breathing, upset stomach, pallor, hair loss, decreased ability to think and joint pain and the beginning of neurological symptoms, including abnormal sensations such as, numbness and tingling, and tinnitus may occur

BPC-157's action also includes counteracting portal hypertension and liver-stomach hypertension

Angiogenic effects supporting revascularization

WHO CAN BENEFIT

Rejoin your Connect Group or explore new sessions and connections